ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,502 | +7.8% | 119,258 | +17.2% | 0.00% | – |
| Q2 2023 | $163,758 | -24.4% | 101,713 | +36.2% | 0.00% | – |
| Q1 2023 | $216,642 | -4.5% | 74,704 | +8.0% | 0.00% | – |
| Q4 2022 | $226,812 | +69.3% | 69,150 | +95.1% | 0.00% | – |
| Q3 2022 | $133,948 | -51.5% | 35,436 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $276,000 | -12.9% | 35,436 | +3.7% | 0.00% | 0.0% |
| Q1 2022 | $317,000 | -38.3% | 34,176 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $514,000 | -13.2% | 32,621 | -1.4% | 0.00% | 0.0% |
| Q3 2021 | $592,000 | +15.2% | 33,080 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $514,000 | +4.7% | 33,080 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $491,000 | -21.6% | 34,189 | +7.3% | 0.00% | 0.0% |
| Q4 2020 | $626,000 | +100.6% | 31,865 | +32.2% | 0.00% | 0.0% |
| Q3 2020 | $312,000 | +7.2% | 24,098 | +20.7% | 0.00% | 0.0% |
| Q2 2020 | $291,000 | +33.5% | 19,970 | -22.1% | 0.00% | 0.0% |
| Q1 2020 | $218,000 | -45.8% | 25,632 | +4.9% | 0.00% | 0.0% |
| Q4 2019 | $402,000 | +55.2% | 24,431 | +33.1% | 0.00% | 0.0% |
| Q3 2019 | $259,000 | -26.8% | 18,362 | +4.2% | 0.00% | 0.0% |
| Q2 2019 | $354,000 | -48.1% | 17,619 | +2.8% | 0.00% | -50.0% |
| Q1 2019 | $682,000 | +14.4% | 17,145 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $596,000 | -10.1% | 17,145 | +7.0% | 0.00% | 0.0% |
| Q3 2018 | $663,000 | +12.6% | 16,022 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $589,000 | +7.5% | 16,022 | +14.1% | 0.00% | 0.0% |
| Q1 2018 | $548,000 | +156.1% | 14,043 | +18.9% | 0.00% | – |
| Q4 2017 | $214,000 | +9.2% | 11,813 | 0.0% | 0.00% | – |
| Q3 2017 | $196,000 | +18.8% | 11,813 | 0.0% | 0.00% | – |
| Q2 2017 | $165,000 | -21.1% | 11,813 | +16.2% | 0.00% | – |
| Q1 2017 | $209,000 | +45.1% | 10,162 | 0.0% | 0.00% | – |
| Q4 2016 | $144,000 | -33.6% | 10,162 | 0.0% | 0.00% | – |
| Q3 2016 | $217,000 | -5.2% | 10,162 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $229,000 | +3.6% | 10,162 | +44.4% | 0.00% | 0.0% |
| Q3 2015 | $221,000 | -40.4% | 7,035 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $371,000 | – | 7,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |